Foley Attorneys Named to 2022 Wisconsin Super Lawyers and Rising Stars Lists
November 15, 2022
Foley & Lardner LLP is pleased to announce that 16 of its attorneys were selected for inclusion in the 2022 Wisconsin Super Lawyers and Rising Stars lists.
Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high degree of peer recognition and professional achievement. The patented selection process includes independent research, peer nominations, and peer evaluations. Each year, only 5 percent of attorneys in the state are selected to the Super Lawyers list.
2022 Wisconsin Super Lawyers
Madison
- Daniel Kaplan, Employment & Labor
- Naikang Tsao, IP Litigation
Milwaukee
- Linda Benfield, Environmental
- James Clark, Business Litigation
- Michael Hatch, Real Estate
- James McKeown, Antitrust Litigation
- Thomas Shriner Jr., General Litigation
2022 Wisconsin Rising Stars
Madison
- Eric Hatchell, Business Litigation
- Jennifer Luther, Civil Litigation: Defense
- Samuel Robertson, Estate & Probate
Milwaukee
- Gregory Heinen, Business Litigation
- William Hughes, Estate & Probate
- Jessica Lothman, Government Finance
- Andrew Meerkins, Business Litigation
- Joshua Roling, Real Estate
- Morgan Tilleman, Mergers & Acquisitions
People
Related News
June 22, 2026
In the News
Aaron Maguregui Authors Article on Building Scalable, Secure AI Strategies
Foley & Lardner LLP partner Aaron Maguregui authored the HealthTech article, “A Digital Health CEO’s Guide to Fast, Secure Scaling of AI,” offering guidance to digital health leaders on artificial intelligence scaling.
June 5, 2026
In the News
Jeffrey Blease Featured Across the Media for Litigation Department Chair Appointment
Foley & Lardner LLP partner Jeffrey Blease is featured across legal media for his recent appointment as chair of the firm's national litigation department.
June 5, 2026
In the News
David Rosen Discusses SCOTUS Ruling on Generic Drug Labeling
Foley & Lardner LLP partner David Rosen is quoted across the media for his analysis of the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.